Literature DB >> 7625503

Spermicide acceptability among patients at a sexually transmitted disease clinic in Zambia.

S K Hira1, A B Spruyt, P J Feldblum, M R Sunkutu, L H Glover, M J Steiner.   

Abstract

OBJECTIVE: This study assessed the acceptability of three nonoxynol-9 spermicides among persons attending a sexually transmitted disease clinic in Lusaka, Zambia.
METHODS: Spermicidal foam, suppositories, and foaming tablets were evaluated. Women (n = 114) and men (n = 150) attending an sexually transmitted disease clinic were enrolled. After each participant used two products, each for 2 weeks, consistency of use and acceptability were evaluated.
RESULTS: At admission, most women (74%) and men (58%) were not using any family planning method. Moreover, most women (85%) and men (98%) had at least one sexually transmitted disease or genital infection. During the study, the proportion of coital episodes protected by spermicide use was high, yet loss to follow-up and discontinuation were also substantial. Discontinuation was frequently unrelated to acceptability. Women and men rated all three products positively along several acceptability parameters. Foam was the least desirable delivery system due to excess messiness.
CONCLUSIONS: The results of this study suggest that it is feasible to distribute spermicides to women and men at increased risk for sexually transmitted disease and that the products will be used. Further research should be done among different populations and include other spermicidal delivery mechanisms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7625503      PMCID: PMC1615820          DOI: 10.2105/ajph.85.8_pt_1.1098

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  20 in total

1.  Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections.

Authors:  S Niruthisard; R E Roddy; S Chutivongse
Journal:  Lancet       Date:  1992-06-06       Impact factor: 79.321

Review 2.  Family planning, sexually transmitted diseases and contraceptive choice: a literature update--Part I.

Authors:  W Cates; K M Stone
Journal:  Fam Plann Perspect       Date:  1992 Mar-Apr

Review 3.  Sexual transmission of human immunodeficiency virus: virus entry into the male and female genital tract. World Health Organization, Global Programme on Acquired Immune Deficiency Syndrome.

Authors:  N J Alexander
Journal:  Fertil Steril       Date:  1990-07       Impact factor: 7.329

Review 4.  Comparative contraceptive efficacy of the female condom and other barrier methods.

Authors:  J Trussell; K Sturgen; J Strickler; R Dominik
Journal:  Fam Plann Perspect       Date:  1994 Mar-Apr

5.  Effect of the contraceptive sponge on chlamydial infection, gonorrhea, and candidiasis. A comparative clinical trial.

Authors:  M J Rosenberg; W Rojanapithayakorn; P J Feldblum; J E Higgins
Journal:  JAMA       Date:  1987-05-01       Impact factor: 56.272

6.  A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections.

Authors:  W C Louv; H Austin; W J Alexander; S Stagno; J Cheeks
Journal:  J Infect Dis       Date:  1988-09       Impact factor: 5.226

Review 7.  Personal protection against sexually transmitted diseases.

Authors:  K M Stone; D A Grimes; L S Magder
Journal:  Am J Obstet Gynecol       Date:  1986-07       Impact factor: 8.661

8.  Barrier-method contraceptives and pelvic inflammatory disease.

Authors:  J Kelaghan; G L Rubin; H W Ory; P M Layde
Journal:  JAMA       Date:  1982-07-09       Impact factor: 56.272

9.  Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes.

Authors:  J Kreiss; E Ngugi; K Holmes; J Ndinya-Achola; P Waiyaki; P L Roberts; I Ruminjo; R Sajabi; J Kimata; T R Fleming
Journal:  JAMA       Date:  1992 Jul 22-29       Impact factor: 56.272

10.  Contraceptive needs and practices among women attending an inner-city STD clinic.

Authors:  D M Upchurch; M Y Farmer; D Glasser; E W Hook
Journal:  Am J Public Health       Date:  1987-11       Impact factor: 9.308

View more
  5 in total

1.  Willingness to use microbicides is affected by the importance of product characteristics, use parameters, and protective properties.

Authors:  Kathleen M Morrow; Joseph L Fava; Rochelle K Rosen; Sara Vargas; Candelaria Barroso; Anna L Christensen; Cynthia Woodsong; Lawrence Severy
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

Review 2.  Reproductive health: an international perspective.

Authors:  D E Greydanus; P Senanayake; M J Gains
Journal:  Indian J Pediatr       Date:  1999 May-Jun       Impact factor: 1.967

3.  A Sexual Barrier Intervention for HIV+/- Zambian Women: Acceptability and Use of Vaginal Chemical Barriers.

Authors:  Deborah L Jones; Stephen M Weiss; Ganapati J Bhat; Douglas Feldman; Violet Bwalya; Danielle Budash
Journal:  J Multicult Nurs Health       Date:  2004-01-01

4.  User preferences in a carrageenan-based vaginal drug delivery system.

Authors:  Bangde Li; Toral Zaveri; Gregory R Ziegler; John E Hayes
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

5.  Communication About Microbicide Use Between Couples in KwaZulu-Natal, South Africa.

Authors:  Mitzy Gafos; Robert Pool; Misiwe Adelaide Mzimela; Hlengiwe Beauty Ndlovu; Sheena McCormack; Jonathan Elford
Journal:  AIDS Behav       Date:  2015-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.